Histamine H2 receptor antagonist exhibited comparable all-cause mortality-decreasing effect as β-blockers in critically ill patients with heart failure: a cohort study

Histamine H2 receptor antagonist exhibited comparable all-cause mortality-decreasing effect as β-blockers in critically ill patients with heart failure: a cohort study

Background: Our previous study reported that histamine H2 receptor antagonists (H2RAs) exposure was associated with decreased mortality in critically ill patients with heart failure (HF) through the same pharmacological mechanism as β-blockers. However, population-based clinical study directly compa...

Full description

Bibliographic Details
Main Authors: Xue-Sha Zhang, Wen-Ke Cai, Ping Wang, Ran Xu, Sun-Jun Yin, Yan-Hua Huang, Yu Guo, Fang-Fang Jiang, Jian-Mei Pan, Yi-Hua Li, Gong-Hao He
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Pharmacology
Subjects:
histamine H2 receptor antagonists
β-blockers
heart failure
mortality
medical information mart for intensive care
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1273640/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2023.1273640/full

Similar Items